Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories

There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on TeraWulf Inc (WULF – Research Report) and American Bi...

Analysts Are Bullish on These Financial Stocks: TeraWulf Inc (WULF), American Bitcoin Corp (ABTC)

Income-focused investors can rely on time-tested dividend aristocrats to generate much of their portfolio’s cash flow, delivering steady payouts ri...

3 Best Dividend Aristocrat Stocks to Buy Now, 02/26/2026

Abbott Laboratories ( ($ABT) ) has issued an announcement. On February 20, 2026, Abbott Laboratories’ board of directors approved an amendment to t...

Abbott Laboratories Streamlines Governance With Smaller Board

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Crinetics Pharmaceuticals (CRNX – Research Report) a...

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and Abbott Laboratories (ABT)

Insiders have been trading these 5 stocks: (($ABT)), (($HIMS)), (($AXP)), (($UAL)) and (($CMCSA)). Here is a breakdown of their recent trades and t...

Abbott, Hims, AmEx, United, Comcast: Insider Moves Exposed

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mettler-Toledo (MTD – Research Report) and Abbott La...

Analysts’ Top Healthcare Picks: Mettler-Toledo (MTD), Abbott Laboratories (ABT)

For investors focused on steady cash flow, long-tenured dividend aristocrats offer a reliable way to secure consistent payout streams throughout 20...

3 Best Dividend Aristocrat Stocks to Buy Now, 02/04/2026

BTIG analyst Marie Thibault maintained a Buy rating on Abbott Laboratories yesterday and set a price target of $140.00. The company’s shares closed...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ABT	$113.45	-0.14%	2.34M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ABT	$113.45	-0.1%	2.34M
3
4
5
6

ABT

ABT

Get Abbott Laboratories Data in Excel

Get Abbott Laboratories Data in Excel